Morocco's ABA Life Secures $40M from Admaius to Scale Sovereign Health AI

Moroccan healthtech enterprise ABA Life has entered into a $40 million investment agreement with pan-African private equity manager Admaius Capital Partners, according to reporting by Wamda. The transaction remains subject to customary closing conditions alongside regulatory approval from the Competition Council of the Kingdom of Morocco.

Established in 2021 as the healthcare arm of ABA Technology, the firm integrates clinical artificial intelligence, telemedicine tools, connected medical equipment, and on-the-ground healthcare services. According to company disclosures reported by Wamda, ABA Life has established a profitable commercial model by rolling out large-scale diagnostic and monitoring programmes in partnership with domestic public institutions and charitable foundations.

The growth equity will primarily finance the enterprise's "AI for Sovereign Health" roadmap. According to company leadership, the initiative centres on expanding the capabilities of its proprietary Mediot AI platform and specialised clinical intelligence applications. The new funds will also support the manufacturing and deployment of connected medical equipment, alongside financing planned expansion into international markets.

Selim Ettriqui, Head of Morocco and West Africa at Admaius Capital Partners, said the firm was impressed by ABA Life's integrated model combining medical devices, connected infrastructure, care operations and proprietary technology developed in Morocco. Mohamed Benouda, founder and chairman of ABA Technology, said the company aims to develop a new generation of clinical intelligence in Morocco and take it to international markets.

What it means

For emerging economies, the deal indicates that pairing proprietary clinical artificial intelligence with locally manufactured hardware provides a durable pathway to technological sovereignty and expanded public healthcare delivery across the Global South.